3/A

PRIMARY DOCUMENT

Company: HERON THERAPEUTICS, INC. /DE/
Filed: September 24, 2012
Period of Report: July 25, 2012
Accession Number: 0001426812-12-000006

View Document ↗ View on SEC.gov ↗